Ospedale San Paolo
- Address
- Largo Donatori del Sangue, 1, 00053 Civitavecchia, Italy
Ospedale San Paolo - Advanced Lung Cancer Research
Ospedale San Paolo is actively engaged in cutting-edge oncology research, with a particular emphasis on advanced therapeutic strategies for lung cancer. The center specializes in investigating novel combination therapies and immunotherapy approaches for patients with progressive metastatic disease who have failed initial treatment lines.
- Metastatic non-small-cell lung cancer (NSCLC) combination therapies
- Second-line treatment strategies following chemo-immunotherapy failure
- Immunotherapy and targeted therapy combinations in advanced lung cancer
The research center demonstrates expertise in conducting complex multicenter Phase II trials evaluating innovative treatment combinations. Their work focuses on improving survival outcomes for patients with metastatic NSCLC through the investigation of novel immunotherapeutic agents combined with established chemotherapy regimens, addressing the critical need for effective second-line therapies in this challenging patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Fondazione Ricerca Traslazionale1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ospedale San Paolo
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase II Randomized Trial of Tedopi with Docetaxel or Nivolumab in Metastatic NSCLC Post-Chemoimmunotherapy | Fondazione Ricerca Traslazionale | Phase II | Recruiting | Feb 2025 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala | 1 | Unknown | 2025-02-07 | 2025-02-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.